New York State Common Retirement Fund
VOR icon

New York State Common Retirement Fund’s Vor Biopharma VOR Stock Holding History

New York State Common Retirement Fund’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$263K Buy
+14,300
New +$216K ﹤0.01% 2251
2024
Q3 		– Sell
-16
Closed -$322 – 3347
2024
Q2 		$322 Sell
16
-1,077
-99% -$34.8K ﹤0.01% 3363
2024
Q1 		$51.8K Buy
1,093
+18
+2% +$790 ﹤0.01% 2972
2023
Q4 		$48.4K Sell
1,075
-6
-0.6% -$248 ﹤0.01% 3007
2023
Q3 		$45.8K Buy
1,081
+21
+2% +$1.14K ﹤0.01% 3046
2023
Q2 		$65.5K Buy
+1,060
New +$96.8K ﹤0.01% 3075
2022
Q3 		– Sell
-10
Closed -$1K – 3458
2022
Q2 		$1K Sell
10
-525
-98% -$53.7K ﹤0.01% 3419
2022
Q1 		$65K Buy
535
+3
+0.6% +$511 ﹤0.01% 3115
2021
Q4 		$124K Buy
532
+142
+36% +$40.9K ﹤0.01% 3021
2021
Q3 		$122K Sell
390
-175
-31% -$52K ﹤0.01% 3079
2021
Q2 		$211K Buy
565
+135
+31% +$66.6K ﹤0.01% 3024
2021
Q1 		$371K Buy
+430
New +$364K ﹤0.01% 2584

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

New York State Common Retirement Fund's VOR Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Vor Biopharma (VOR) in Q2 2026: 14,300 shares worth $263K. The stake represents ﹤0.01% of the portfolio and ranks #2251 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in VOR as recently as Q2 2024.

New York State Common Retirement Fund first reported a position in VOR in Q1 2021 and has held it in 12 quarters since. The position peaked at $371K in Q1 2021. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • New York State Common Retirement Fund held 14,300 shares of Vor Biopharma worth $263K as of Q2 2026.
  • Vor Biopharma was a new New York State Common Retirement Fund position in Q2 2026.
  • Vor Biopharma made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2251 holding.
  • New York State Common Retirement Fund first reported a position in Vor Biopharma in Q1 2021 and has held it in 12 quarters since.
  • New York State Common Retirement Fund's Vor Biopharma position peaked at $371K in Q1 2021.
  • 102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.